RARE
Ultragenyx
15.20$
+3.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +20.4% | -12.3% | +23.8% | -4.9% | -2.3% | -12.7% | -0.4% | -8.9% | +28.7% | -15.4% | -2.5% | |
| – | +22.2% | -18.6% | +61.9% | -17.1% | +2.2% | -14.4% | +3.0% | -10.6% | +47.9% | -30.9% | -7.8% | |
| – | +194.3% | -47.4% | +328.2% | -68.7% | +15.3% | -26.9% | +30.7% | +27.8% | +104.4% | -59.7% | -28.6% | |
| – | +30.6% | -28.6% | +85.4% | -18.6% | -1.9% | -18.9% | -3.4% | -8.9% | +59.3% | -40.4% | -29.3% | |
| – | -7.4% | +36.6% | +5.7% | -12.0% | +30.5% | -18.9% | +25.9% | -7.9% | +38.7% | -23.9% | +65.3% | |
| – | +6.8% | +5.7% | +11.8% | +8.0% | +3.9% | +2.3% | +1.0% | +12.3% | -0.4% | +5.8% | +7.3% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -0.9% | +0.0% | +0.0% | |
| – | +5.7% | -0.7% | +0.7% | -0.8% | +8.1% | -1.0% | -1.0% | -1.0% | +1.8% | -1.1% | -1.1% | |
| – | +0.8% | -4.0% | +1.6% | -0.1% | +4.8% | -6.5% | -1.1% | +2.3% | +36.7% | -5.0% | +1.5% | |
| – | +10.4% | -12.4% | +11.1% | +4.4% | +20.8% | -15.3% | +0.5% | +16.0% | +12.9% | -15.4% | +8.0% | |
| – | +4.4% | +1.5% | -8.3% | -11.0% | -1.2% | +1.8% | +12.2% | +560.3% | +4.3% | -11.1% | +5.6% | |
| – | +26.3% | -2.7% | +46.0% | -39.8% | +7.7% | +22.4% | -27.8% | +18.5% | -23.6% | +35.5% | -7.1% | |
| – | +768.4% | -49.1% | +208.3% | -19.8% | -26.4% | -43.5% | +4.9% | -93.9% | -973.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +13.2% | +3.9% | +2.7% | +10.3% | +0.2% | +0.6% | +2.3% | +1.3% | +0.1% | +0.7% | +1.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.